Assistant Clinical Professor, Department of Medicine, Université de Montréal

Topic: The next frontier of toxicity anti-cancer research

Dr Arielle Elkrief, MD is a medical oncologist and clinician scientist specializing in the care of patients with lung cancer and melanoma. After completing her medical oncology specialization at McGill University, she completed a research fellowship at Memorial Sloan Kettering Cancer Center in New York. There, she focused on functional genomic approaches and developed new biomarkers and treatments for patients with cancer. Dr. Elkrief also serves as the Medical Director for the CHUM Microbiome Centre where she designs clinical trials that are focused on the gut microbiome.